Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-208.84M
↓ 62% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-129.15M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-208.84M | -14.2% |
| 2024 | $-182.94M | -12.0% |
| 2023 | $-163.40M | -41.6% |
| 2022 | $-115.41M | -51.4% |
| 2021 | $-76.24M | -171.7% |
| 2020 | $-28.06M | - |